drugset / Trial / NCT00555880
Study to Assess the Benefit of Midodrine in the Treatment of Patients With Neurogenic Orthostatic Hypotension
RandomizedCrossoverQuadruple-blindTreatment
Summary
The purpose of this clinical study is to evaluate the clinical effect of midodrine hydrochloride (ProAmatine®) compared to placebo in patients with orthostatic hypotension by measuring the time to onset of near syncopal symptoms and assessing several cardiovascular measurements, such as heart rate, blood pressure, and ECG, using the tilt table test.
Timeline
- Start
- 2004-09-08
- Primary completion
- 2005-03-21
- Completion
- 2005-03-21
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Midodrine | Small molecule | 10 mg | Oral |
| Subject | Midodrine | Small molecule | 30 mg | Oral |